A Randomised Phase II Study of Pegylated Liposomal Doxorubicine in Elderly Patients with Acute Lymphoblastic Leukemia (ALL): The GRAALL-SA1 Study

被引：0
|
作者：
Hunault-Berger, Mathilde
Leguay, Thibaut [1 ]
Thomas, Xavier [2 ]
Legrand, Ollivier [3 ]
Huguet, Francoise [4 ]
Witz, Francis [5 ]
Escoffre-Barbe, Martine [6 ]
Legros, Laurence [7 ]
Turlure, Pascal [8 ]
Chevallier, Patrice [9 ]
Larosa, Fabrice [10 ]
Cahn, Jean-Yves
Reman, Oumedaly [11 ]
Rousselot, Philippe [12 ,13 ]
Delannoy, Andre [14 ]
Dhedin, Nathalie [15 ]
Pochitaloff, Marina [16 ]
Bene, Marie-Christine
Ifrah, Norbert [17 ]
Dombret, Herve [18 ]
机构：
[1] CH Bordeaux, Bordeaux, France
[2] GRAAL Grp, Lyon, France
[3] Hop Hotel Dieu, F-75181 Paris, France
[4] CHU Toulouse, Toulouse, France
[5] Hop Brabois, Nancy, France
[6] Hop Pontchaillou, Hematol Clin, Rennes, France
[7] CHU Nice, Nice, France
[8] CHU Limoges, Limoges, France
[9] CHU Hotel Dieu, Nantes, France
[10] CHU Jean Minjoz, INSERM, UMR645, Besancon, France
[11] CHU Caen, F-14000 Caen, France
[12] Hop Mignot, Versailles, France
[13] CIC9504, Versailles, France
[14] Hop Jolimont, Haine St Paul, Belgium
[15] Hop La Pitie Salpetriere, Serv Hematol Clin, Paris, France
[16] Cytogenet, Marseille, France
[17] CHU Angers, Serv Malad Sang, Angers, France
[18] Hop St Louis, AP HP, Paris, France
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [31] Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Wetzler, Meir
    Thomas, Debora A.
    Wang, Eunice S.
    Shepard, Robert
    Ford, Laurie A.
    Heffner, Thompson L.
    Parekh, Samir
    Andreeff, Michael
    O'Brien, Susan
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 430 - 434
  • [32] Phase II study of marqibo in adult patients with refractory or relapsed philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL)
    O'Brien, S. M.
    Aulitzky, W.
    Ben Yehuda, D.
    Lister, J.
    Schiller, G. J.
    Selter, K.
    Smith, S. E.
    Stock, W.
    Silverman, J. A.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Phase II Study of Combination of hyperCVAD with Dasatinib in Frontline Therapy of Patients with Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL)
    Ravandi, Farhad
    Thomas, Deborah
    Kantarjian, Hagop
    Faderl, Stefan
    Koller, Charles
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Borthakur, Gautam
    Wierda, William
    Burger, Jan
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2008, 112 (11) : 1005 - 1005
  • [34] Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer
    Rivera, E
    Valero, V
    Arun, B
    Royce, M
    Adinin, R
    Hoelzer, K
    Walters, R
    Wade, JL
    Pusztai, L
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3249 - 3254
  • [35] Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study
    Collea, R. P.
    Kruter, F. W.
    Cantrell, J. E.
    George, T. K.
    Kruger, S.
    Favret, A. M.
    Lindquist, D. L.
    Melnyk, A. M.
    Pluenneke, R. E.
    Shao, S. H.
    Crockett, M. W.
    Asmar, L.
    O'Shaughnessy, J.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2599 - 2605
  • [36] Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, Vita
    Palmisano, Valentina
    Pepe, Alessio
    Usset, Antonella
    Manuguerra, Giovanna
    Savio, Giuseppina
    De Bella, Manuela Tamburo
    Laudani, Agata
    Alu, Massimo
    Cusimano, Maria Pia
    Scianna, Caterina
    Giresi, Armando
    Agostara, Biagio
    ONCOLOGY LETTERS, 2010, 1 (04) : 749 - 753
  • [37] A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial
    DeAngelo, Daniel J.
    Stevenson, Kristen
    Neuberg, Donna S.
    Silverman, Lewis B.
    Ballen, Karen K.
    Asch, Julie D.
    Abou Mourad, Yasser
    Paulson, Kristjan
    Seftel, Matthew D.
    Avigan, David
    Bergeron, Julie
    Couban, Stephen
    Blum, William
    Storring, John
    Wadleigh, Martha
    Steensma, David P.
    Supko, Jeffrey
    Sallan, Stephen E.
    Stone, Richard M.
    BLOOD, 2015, 126 (23)
  • [38] Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
    Delannoy, A.
    Delabesse, E.
    Lheritier, V.
    Castaigne, S.
    Rigal-Huguet, F.
    Raffoux, E.
    Garban, F.
    Legrand, O.
    Bologna, S.
    Dubruille, V.
    Turlure, P.
    Reman, O.
    Delain, M.
    Isnard, F.
    Coso, D.
    Raby, P.
    Buzyn, A.
    Cailleres, S.
    Darre, S.
    Fohrer, C.
    Sonet, A.
    Bilhou-Nabera, C.
    Bene, M-C
    Dombret, H.
    Berthaud, P.
    Thomas, X.
    LEUKEMIA, 2006, 20 (09) : 1526 - 1532
  • [39] Treatment of acute lymphoblastic leukemia (ALL) in the elderly: A feasibility study of interferon during maintenance.
    Sebban, C
    Delannoy, A
    Tabah, I
    ConyMakhoun, P
    Cazin, B
    Cordonnier, C
    Bouabdallah, R
    Cahn, JY
    Dreyfus, F
    Sadoun, A
    Gay, C
    Broustet, A
    Michaux, JL
    Fiere, D
    BLOOD, 1995, 86 (10) : 3105 - 3105
  • [40] A phase II "Window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia
    Gore, SD
    Rowinsky, EK
    Miller, CB
    Griffin, C
    Chen, TL
    Borowitz, M
    Donehower, RC
    Burks, KL
    Armstrong, DK
    Burke, PJ
    Grever, MR
    Kaufmann, SH
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2677 - 2689
12345